Related references
Note: Only part of the references are listed.The Burden of Non-Adherence to Cardiovascular Medications Among the Aging Population in Australia: A Meta-Analysis
Samantha J. McKenzie et al.
DRUGS & AGING (2015)
Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland
M. P. O'Shea et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2015)
Heart Disease and Stroke Statistics-2015 Update A Report From the American Heart Association
Dariush Mozaffarian et al.
CIRCULATION (2015)
Secondary Prevention of Stroke in the Elderly: Focus on Drug Therapy
Martinson K. Arnan et al.
DRUGS & AGING (2014)
Intentional Non-Adherence to Medications by Older Adults
Omar Mukhtar et al.
DRUGS & AGING (2014)
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Walter N. Kernan et al.
STROKE (2014)
Cardiovascular disease in Europe: epidemiological update
Melanie Nichols et al.
EUROPEAN HEART JOURNAL (2013)
Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry
Ruijun Ji et al.
NEUROLOGICAL RESEARCH (2013)
A new taxonomy for describing and defining adherence to medications
Bernard Vrijens et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Persistence, Adherence and Outcomes with Antiplatelet Regimens following Cerebral Infarction in the Tayside Stroke Cohort
Robert W. V. Flynn et al.
CEREBROVASCULAR DISEASES (2012)
Patient empowerment and optimal glycemic control
Russell D. White
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data
Kamilla Ostergaard et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Comparative persistence and adherence to overactive bladder medications in patients with and without diabetes
S. Johnston et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Secondary preventive medication persistence and adherence 1 year after stroke
C. D. Bushnell et al.
NEUROLOGY (2011)
Persistence With Stroke Prevention Medications 3 Months After Hospitalization
Cheryl D. Bushnell et al.
ARCHIVES OF NEUROLOGY (2010)
Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors
James P. Burke et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After Stroke
Eva-Lotta Glader et al.
STROKE (2010)
Persistence with statin therapy in diabetic and non-diabetic persons: a nation-wide register study in 1995-2005 in Finland
Arja Helin-Salmivaara et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Medication persistence rates and factors associated with persistence in patients following stroke: A cohort study
Heather L. Lummis et al.
BMC NEUROLOGY (2008)
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 - The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee
Werner Hacke et al.
CEREBROVASCULAR DISEASES (2008)
Medication compliance and persistence: Terminology and definitions
Joyce A. Cramer et al.
VALUE IN HEALTH (2008)
Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study
JA Erkens et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Risk factors, outcome, and treatment in subtypes of ischemic stroke - The German Stroke Data Bank
AJ Grau et al.
STROKE (2001)
Share Paper
